| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769299 | Actas Urológicas Españolas | 2017 | 12 Pages |
Abstract
The benefit of RP might be overestimated, given that the risk of MOC is greater than that of CSM, regardless of the age group and risk group, especially after 10Â years of follow-up. The only parameter that varied was the magnitude of the CSM/MOC ratio. This information could help in choosing the active treatment for patients with LPC and short life expectancies.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
J.L. Ruiz-Cerdá, A. Soto-Poveda, S. Luján-Marco, A. Loras-Monfort, M. Trassierra-Villa, R. Rogel-Bertó, F. Boronat-Tormo,